http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H09249751-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ce40bbce9138dae1d3765564fdca6772 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08H1-00 |
| filingDate | 1996-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2958565e9c7bb2c5078c27d624eec4ba |
| publicationDate | 1997-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H09249751-A |
| titleOfInvention | Use of hydrophobic crosslinkers for preparing crosslinked biomaterial compositions |
| abstract | (57) Abstract: A hydrophobic cross-linking agent is used to provide an injectable or implantable cross-linked biomaterial composition for use in various therapeutic applications. A conjugate containing a biological substance covalently bound to a hydrophobic polymer, wherein the hydrophobic polymer is Conjugates are provided that contain two or more succinimidyl groups prior to binding to the biological material. Also provided is a heterogeneously crosslinked biomaterial composition containing a biomaterial, a hydrophobic crosslinker and a hydrophilic crosslinker. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014128686-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010075201-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003526477-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008194380-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005272398-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004173941-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7741454-B2 |
| priorityDate | 1996-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 104.